81 related articles for article (PubMed ID: 17935542)
1. Learning lessons from REACH.
Kassianos GC
Int J Clin Pract; 2007 Nov; 61(11):1786-8. PubMed ID: 17935542
[No Abstract] [Full Text] [Related]
2. [Implications of the REACH registry for neurologists].
Roquer J
Med Clin (Barc); 2009 Sep; 132 Suppl 2():30-3. PubMed ID: 19631836
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics of patients with cerebrovascular disease in the REACH registry: the Spanish contribution.
Suárez C;
Cerebrovasc Dis; 2007; 24 Suppl 1():89-95. PubMed ID: 17971643
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacoeconomic analysis: results of the REACH registry].
Suárez C; Abadía C; Echevarria A
Med Clin (Barc); 2009 Sep; 132 Suppl 2():41-3. PubMed ID: 19631839
[TBL] [Abstract][Full Text] [Related]
5. [Optimizing overall risk reduction: implications of the REACH registry. Introduction].
Steg G
Med Clin (Barc); 2009 Sep; 132 Suppl 2():1. PubMed ID: 19798791
[No Abstract] [Full Text] [Related]
6. [Introduction. Residual atherothrombotic risk. Does it exist?].
Tavazzi L; Ambrosio G
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):3S-5S. PubMed ID: 18773745
[No Abstract] [Full Text] [Related]
7. Atherothrombotic comorbidity in the rheumatic diseases. The evidence becomes clearer. What should clinicians do?
Del Rincón I
Arthritis Rheum; 2009 Oct; 61(10):1284-6. PubMed ID: 19790116
[No Abstract] [Full Text] [Related]
8. Cardiovascular risk factors in patients at high risk of atherothrombosis: what can be learned from registries?
Goto S
Thromb Haemost; 2008 Oct; 100(4):611-3. PubMed ID: 18841282
[No Abstract] [Full Text] [Related]
9. Diabetic atherothrombosis: helpful adjunctive therapy.
Chesebro JH
Eur Heart J; 2008 Sep; 29(18):2191-2. PubMed ID: 18689803
[No Abstract] [Full Text] [Related]
10. [Inflammation and atherothrombosis. Premature vascular injury. Diagnostic and therapeutic options for primary prevention].
Ortiz Arduán A; Ruiz Ortega M; Cases Amenós A
Nefrologia; 2008; 28 Suppl 3():23-7. PubMed ID: 19018734
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet therapy in type 2 diabetes mellitus.
Angiolillo DJ
Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430
[TBL] [Abstract][Full Text] [Related]
12. Emerging risk factors for atherosclerosis.
John JM; Bhatt DL
Indian Heart J; 2007; 59(1):28-37. PubMed ID: 19098332
[No Abstract] [Full Text] [Related]
13. Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle.
Matsuura E; Kobayashi K; Lopez LR
Autoimmun Rev; 2008 Jan; 7(3):214-22. PubMed ID: 18190881
[TBL] [Abstract][Full Text] [Related]
14. Modulating atherothrombosis: is there a place for vaccines in global prevention strategies?
Becker RC
J Thromb Thrombolysis; 2006 Jun; 21(3):285-6. PubMed ID: 16683223
[No Abstract] [Full Text] [Related]
15. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
[TBL] [Abstract][Full Text] [Related]
16. Role of Chlamydia pneumoniae in atherosclerosis.
Watson C; Alp NJ
Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
[TBL] [Abstract][Full Text] [Related]
17. Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis.
Kim YD; Choi HY; Jung YH; Nam CM; Yang JH; Cho HJ; Nam HS; Lee KY; Heo JH
Neuroepidemiology; 2009; 32(3):201-7. PubMed ID: 19169042
[TBL] [Abstract][Full Text] [Related]
18. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
McGill HC; McMahan CA; Gidding SS
Circulation; 2008 Mar; 117(9):1216-27. PubMed ID: 18316498
[No Abstract] [Full Text] [Related]
19. [Role of biochemical risk factors and markers for the risk of atherosclerosis].
Montagnana M; Lippi G; Salvagno GL; Franchini M; Targher G; Guidi GC
Recenti Prog Med; 2008 Apr; 99(4):215-22. PubMed ID: 18595637
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk assessment and treatment in systemic lupus erythematosus.
Elliott JR; Manzi S
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
